Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The smooth muscle ATP-sensitive potassium (K-ATP) channel is a hetero-octameric protein complex typically composed of four inwardly rectifying potassium channel 6.1 (Kir6.1) subunits and four sulfonylurea receptor 2B (SUR2B) subunits (Source: UniProt P48541, O00559). These channels act as metabolic sensors, coupling the intracellular ATP/ADP ratio to membrane excitability; a decrease in ATP or an increase in ADP triggers channel opening (Source: PubMed PMID: 15556826). In vascular smooth muscle, activation of K-ATP channels leads to potassium efflux and membrane hyperpolarization, which inhibits voltage-gated calcium channels and reduces calcium influx, ultimately promoting vasodilation (Source: StatPearls, \"Potassium Channel Openers\"). This mechanism is essential for regulating systemic blood pressure and local blood flow in response to metabolic stress or pharmacological agents (Source: PubMed PMID: 22503554). Pharmacologically, these channels are targeted by potassium channel openers like minoxidil and nicorandil to treat severe hypertension and angina, while mutations in the encoding genes (KCNJ8 and ABCC9) are linked to Cantu syndrome (Source: NIH Genetic and Rare Diseases Information Center). Beyond the vasculature, these channels are also found in other smooth muscle tissues, such as the bladder and bronchi, where they modulate contractility (Source: PubMed PMID: 11159014).
Activation of the channel by potassium channel openers (KCOs) increases the open-state probability, leading to potassium efflux, membrane hyperpolarization, and subsequent relaxation of smooth muscle (Source: PubMed PMID: 10428313).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Smooth muscle ATP-sensitive potassium channel (K-ATP channel) (K-ATP channel).